Investigational Drug Information for Talampanel
✉ Email this page to a colleague
What is the drug development status for Talampanel?
Talampanel is an investigational drug.
There have been 11 clinical trials for Talampanel.
The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2003.
The most common disease conditions in clinical trials are Sclerosis, Glioblastoma, and Motor Neuron Disease. The leading clinical trial sponsors are Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceutical Industries, and National Institute of Neurological Disorders and Stroke (NINDS).
Summary for Talampanel
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,633 |
| WIPO Patent Applications | 646 |
| Japanese Patent Applications | 128 |
| Clinical Trial Progress | Phase 2 (2003-07-01) |
| Vendors | 37 |
Recent Clinical Trials for Talampanel
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm | Cetero Research, San Antonio | Phase 1 |
| A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 1 |
| A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm | Teva Pharmaceutical Industries | Phase 1 |
Clinical Trial Summary for Talampanel
Top disease conditions for Talampanel
Top clinical trial sponsors for Talampanel
US Patents for Talampanel
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
